THREATPORT/VULNERABILITY/CVE-2021-27290
HIGH SEVERITY

CVE-2021-27290

Ssri vulnerability

CVSS
7.5
EPSS
4.7%
EPSS pct
91th
Exploited
No known
ssri 5.2.2-8.0.0, fixed in 8.0.1, processes SRIs using a regular expression which is vulnerable to a denial of service. Malicious SRIs could take an extremely long time to process, leading to denial of service. This issue only affects consumers using the strict option.
Affected vendor
Ssri Project
Affected product
Ssri
CVSS vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
Published
2021-03-12

Risk analysis

Based on its CVSS vector, this vulnerability is exploitable over the network, low attack complexity, requiring no privileges, no user interaction. Successful exploitation leads to high impact to availability.

Its EPSS score of 4.7% reflects a lower probability of exploitation activity in the wild over the next 30 days, placing it above 91% of all scored CVEs.

Check your external exposure to CVE-2021-27290

  • Confirm whether Ssri Project Ssri is running on any internet-facing host or subdomain.
  • Match discovered service fingerprints against the version affected by CVE-2021-27290.
  • Prioritise remediation if the asset is public, business-critical, or near authentication/payment flows.

How ThreatPort helps with CVE-2021-27290

ThreatPort's external attack surface scanner checks your internet-facing assets — agentlessly, from the outside in — for the exposed services and versions that CVE-2021-27290 affects, then prioritises the finding by real risk using CISA KEV and FIRST.org EPSS.

Run a free external exposure scan

Are you exposed to CVE-2021-27290?

Run an instant, non-intrusive external scan to check your attack surface for CVE-2021-27290.

Start free scan

No credit card. Agentless.